Acutaas Chemicals Limited (BOM:543349)

Market Cap	139.80B
Revenue (ttm)	10.97B
Net Income (ttm)	2.24B
Shares Out	n/a
EPS (ttm)	27.38
PE Ratio	62.42
Forward PE	45.38
Dividend	1.50 (0.09%)
Ex-Dividend Date	Sep 18, 2025

Volume	11,872
Average Volume	16,083
Open	1,749.75
Previous Close	1,744.50
Day's Range	1,727.70 - 1,779.25
52-Week Range	919.63 - 1,901.35
Beta	n/a
RSI	48.02
Earnings Date	Feb 14, 2026

About Acutaas Chemicals

Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson’s, antidepressant, and anticoagulant applications. It also provides specialty chemicals for use in battery chemicals, personal care, agrochemicals, coatings, electronics, and industrial processes; photoresist...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2004
• Employees: 879
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543349

Financial Performance

In 2024, Acutaas Chemicals's revenue was 10.07 billion, an increase of 40.34% compared to the previous year's 7.17 billion. Earnings were 1.59 billion, an increase of 271.06%.